Depending upon the process, the electrode is either consumable, in the case of gas metal arc welding or shielded metal arc welding, or non-consumable, such as in gas tungsten arc welding. For a direct current system, the weld rod or stick may be a cathode for a filling type weld or an anode for other welding processes. For an alternating current arc welder, the welding electrode would not be considered an anode or cathode. Alternating current electrodes
For electrical systems which use alternating current, the electrodes are the connections from the circuitry to the object to be acted upon by the electric current but are not designated anode or cathode because the direction of flow of the electrons changes periodically, usually many times per second. Chemically modified electrodes
Chemically modified electrodes are electrodes that have their surfaces chemically modified to change the electrodes physical, chemical, electrochemical, optical, electrical, and transportive properties. These electrodes are used for advanced purposes in research and investigation. Uses
Electrodes are used to provide current through nonmetal objects to alter them in numerous ways and to measure conductivity for numerous purposes.
Pharmacology
Pharmacodynamics
Bremelanotide is a non-selective agonist of the melanocortin receptors, MC1 through MC5 (with the exception of MC2, the receptor of ACTH), but acting primarily as an MC3 and MC4 receptor agonist. Pharmacokinetics
The bioavailability of bremelanotide with subcutaneous injection is about 100%. Following a subcutaneous injection of bremelanotide, maximal levels occur after about one hour, with a range of 0.5 to 1.0 hours. The plasma protein binding of bremelanotide is 21%. Bremelanotide is metabolized via hydrolysis of its peptide bonds. The elimination half-life of bremelanotide is 2.7 hours, with a range of 1.9 to 4.0 hours. Bremelanotide is excreted 64.8% in urine and 22.8% in feces. Chemistry
Bremelanotide is a cyclic heptapeptide lactam analogue of α-melanocyte-stimulating hormone (α-MSH). It has the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, and is also known as cyclo-[Nle4,Asp5,D-Phe7,Lys10]α-MSH-(4-10). Bremelanotide is an active metabolite of melanotan II that lacks the C-terminal amide group.Aside from melanotan II and endogenous melanocyte-stimulating hormones like α-MSH, other peptide analogues of the same family as bremelanotide include afamelanotide (NDP-α-MSH), modimelanotide, and setmelanotide. History
Studies in the early 1960s showed that administration of α-MSH caused sexual arousal in rats, sparking interest in α-MSH. In the 1980s, scientists at University of Arizona began developing α-MSH and analogs as potential sunless tanning agents.